ClinConnect ClinConnect Logo
Search / Trial NCT04937868

Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients

Launched by UNIVERSITY OF CALIFORNIA, LOS ANGELES · Jun 23, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Blunt Trauma Abdominal Injury Pelvic Injury Spine Injury Genital Injury Vascular Injury Hip Injury Computed Tomography Decision Instrument

ClinConnect Summary

This clinical trial is studying how to identify patients with blunt trauma who are at low risk for serious abdominal or pelvic injuries. The goal is to develop a set of simple guidelines that doctors can use to decide when a CT scan is really necessary. Currently, many patients receive CT scans after trauma, which can expose them to unnecessary radiation and high medical costs, even when they may not have any injuries. By finding reliable criteria to identify those who are truly at risk, the trial aims to reduce the number of CT scans performed, thereby lowering costs and minimizing radiation exposure.

Patients eligible for this trial are those who have experienced blunt trauma and are undergoing a CT scan of their abdomen or pelvis in the emergency department. There are no specific exclusions, so anyone in this situation can potentially participate. During the trial, participants will undergo standard clinical evaluations to assess their injuries before any imaging is done. The researchers will then analyze the findings to develop and test the criteria that would help safely reduce the number of unnecessary scans. If successful, this could lead to safer, more efficient care for future trauma patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Blunt trauma patients who undergo abdominal-pelvic CT imaging during their initial trauma evaluation in the emergency department.
  • Exclusion Criteria:
  • None

About University Of California, Los Angeles

The University of California, Los Angeles (UCLA) is a prestigious academic institution renowned for its commitment to research and innovation in the biomedical field. As a clinical trial sponsor, UCLA leverages its cutting-edge facilities, expert faculty, and collaborative environment to advance medical knowledge and improve patient care. The university is dedicated to conducting rigorous clinical research that adheres to the highest ethical standards, aiming to translate scientific discoveries into effective therapies and interventions. Through its diverse array of clinical trials, UCLA seeks to address critical health challenges while fostering the development of future healthcare leaders.

Locations

Los Angeles, California, United States

Patients applied

0 patients applied

Trial Officials

William R Mower, MD, PhD

Study Director

University of California, Los Angeles

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials